Article Text

Download PDFPDF
Original article
Plasma 25-hydroxyvitamin D and colorectal cancer risk according to tumour immunity status
  1. Mingyang Song1,2,
  2. Reiko Nishihara1,3,
  3. Molin Wang2,
  4. Andrew T Chan4,5,
  5. Zhi Rong Qian3,
  6. Kentaro Inamura3,6,
  7. Xuehong Zhang5,
  8. Kimmie Ng3,
  9. Sun A Kim3,
  10. Kosuke Mima3,
  11. Yasutaka Sukawa3,
  12. Katsuhiko Nosho7,
  13. Charles S Fuchs3,5,
  14. Edward L Giovannucci1,2,5,
  15. Kana Wu1,
  16. Shuji Ogino2,3,5,8
  1. 1Department of Nutrition, Harvard School of Public Health, Boston, Massachusetts, USA
  2. 2Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, USA
  3. 3Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA
  4. 4Division of Gastroenterology, Massachusetts General Hospital, Boston, Massachusetts, USA
  5. 5Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts, USA
  6. 6Laboratory of Human Carcinogenesis, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA
  7. 7Department of Gastroenterology, Rheumatology and Clinical Immunology, Sapporo Medical University School of Medicine, Sapporo, Japan
  8. 8Department of Pathology, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts, USA
  1. Correspondence to Dr Shuji Ogino, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, 450 Brookline Ave, Room M422, Boston, MA 02215, USA; shuji_ogino{at}dfci.harvard.edu

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.